Emfizatamab, CAS 2559704-23-1

Product Description: Emfizatamab is an anti-CD19/CD3E/TNFRSF9/PD-L1 monoclonal antibody[1].

Applications: COVID-19-immunoregulation

Formula: N/A

References: [1]Emfizatamab

CAS Number: 2559704-23-1

Molecular Weight: N/A

Research Area: Inflammation/Immunology

Target: CD19;PD-1/PD-L1;TNF Receptor

• Artikelnummer: MEXHY-P99914-0
• Hersteller: MedChemExpress
• Hersteller Artikelnummer: HY-P99914-0
• Verpackungseinheit: Get quote
• Mengeneinheit: STK
• Konjugat: Unconjugated